Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. Osowiecki

R-Chop Is Not Effective Regimen in CD5(+)DLBCL Diagnosed by Flow-Cytometry/Immunohistochemistry, Karyotype and BCL2/BCL6 Status and Expression

Hematological Oncology

English

Ofatumumab With Ivac for DLBCL Patients Who Failed R-Chop and Were Not Candidates for High-Dose Therapy and Asct - Phase 2 Trial of the Polish Lymphoma Research Group (Plrg-8)

Hematological Oncology

English

Related publications

Elevated Expression of Lag3 Is Associated With Poor Outcome in Patients With DLBCL Treated With R-Chop

Hematological Oncology

English

MYC Expression in Concert With BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients With Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

PLoS ONE

Multidisciplinary

2014

English

Negative Impact of Zoledronic Acid in R-Chop Treated DLBCL With Bone Metastasis

Hematological Oncology

English

Prescribed Regimen Is Effective

BMJ

2010

English

Predictive Value of Interim PET/CT in DLBCL Treated With R-Chop: Meta-Analysis

BioMed Research International

English

Clinical Significance and Outcomes in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) Harboring Extra Copies [Ec] and/or Translocations [Tl] of Myc, Bcl2, and Bcl6

Hematological Oncology

English

Granisetron Plus Aprepitant Versus Granisetron in Preventing Nausea and Vomiting During CHOP or R-Chop Regimen in Malignant Lymphoma: A Retrospective Study

Journal of Pharmaceutical Health Care and Sciences

2019

English

Addition of Lenalidomide to R-Chop (R2chop) Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma (Dlbcl): First Report of Ecog-Acrin1412 a Randomized Phase 2 Us Intergroup Study of R2chop vs R-Chop

Hematological Oncology

English

Bet Inhibitor Rg6146, Venetoclax, and Rituximab Is a Highly Active Regimen in Relapsed/Refractory (R/R) Dlbcl: Initial Report of Phase 1b Safety, Biomarker, and Response Data

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. Osowiecki

R-Chop Is Not Effective Regimen in CD5(+)DLBCL Diagnosed by Flow-Cytometry/Immunohistochemistry, Karyotype and BCL2/BCL6 Status and Expression

Ofatumumab With Ivac for DLBCL Patients Who Failed R-Chop and Were Not Candidates for High-Dose Therapy and Asct - Phase 2 Trial of the Polish Lymphoma Research Group (Plrg-8)

Related publications

Elevated Expression of Lag3 Is Associated With Poor Outcome in Patients With DLBCL Treated With R-Chop

MYC Expression in Concert With BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients With Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

Negative Impact of Zoledronic Acid in R-Chop Treated DLBCL With Bone Metastasis

Prescribed Regimen Is Effective

Predictive Value of Interim PET/CT in DLBCL Treated With R-Chop: Meta-Analysis

Clinical Significance and Outcomes in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) Harboring Extra Copies [Ec] and/or Translocations [Tl] of Myc, Bcl2, and Bcl6

Granisetron Plus Aprepitant Versus Granisetron in Preventing Nausea and Vomiting During CHOP or R-Chop Regimen in Malignant Lymphoma: A Retrospective Study

Addition of Lenalidomide to R-Chop (R2chop) Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma (Dlbcl): First Report of Ecog-Acrin1412 a Randomized Phase 2 Us Intergroup Study of R2chop vs R-Chop

Bet Inhibitor Rg6146, Venetoclax, and Rituximab Is a Highly Active Regimen in Relapsed/Refractory (R/R) Dlbcl: Initial Report of Phase 1b Safety, Biomarker, and Response Data